Several lines of evidences suggest that PLEK2 is a potential therapeutic target for the treatment of cancers (Zhao et al., 2018; Shen et al., 2019; Wu et al., 2020; Liu et al., 2021; Wang et al., 2021a; Yang et al., 2021). Here, PLEK2 is linked to cancer.